Send us a text

Join us for a relaxed round up of recent Red Whale primary care Pearls of wisdom. This month, Nik and Caroline discuss: 

• GLP-1 mimetics shortages: tackling drug swaps. The headline grabbing GLP-1 mimetics are rarely out of the news- most recently due to supply issues for people with type 2 diabetes. How do we deal with this?
• Tics and Tourette’s syndrome: spotting them in primary care. Singer-songwriter Lewis Capaldi has been keen to dispel myths that Tourette’s is all about swearing uncontrollably. We share what you need to know. 
• Blepharitis: it’s pretty common and is responsible for about 5% of primary care eye consultations- so worth a reminder about diagnosis and management, to stop you from getting stuck! 
• Molluscum contagiosum…a nuisance but not a spell! We look at the diagnosis, management, who needs referral, and when to think about immunosuppression.

And hear about a multitasking, time pressured, dance themed debacle…

Links
You can check availability of insulin brands at:
www.sps.nhs.uk 

Tourette's Action (UK support group for those with an established diagnosis):
https://www.tourettes-action.org.uk/

Molluscum contagiosum images:
https://www.pcds.org.uk/clinical-guidance/molluscum-contagiosum#management

https://dermnetnz.org/topics/molluscum-contagiosum

Send us your feedback podcast@redwhale.co.uk or send a voice message

Sign up to receive Pearls here. Pearls are available for 3 months from publish date. After this, you can get access them plus 100s more articles when you buy a one-day online course from Red Whale OR sign up to Red Whale Unlimited. Find out more here.

Follow us: X, Facebook, Instagram, LinkedIn

Disclaimer: We make every effort to ensure the information in this podcast is accurate and correct at the date of publication, but it is of necessity of a brief and general nature, and this should not replace your own good clinical judgement, or be regarded as a substitute for taking professional advice in appropriate circumstances. In particular, check drug doses, side-effects and interactions with the British National Formulary. Save insofar as any such liability cannot be excluded at law, we do not accept any liability for loss of any type caused by reliance on the information in this podcast.